What We Do
The Possibilities Are Endless:
Building Communities of Innovation and Impact
Smart solutions are at the core of all that we do. OniX's main goal is finding smart ways of using technology that will facilitate research partnerships to build a better tomorrow for everyone, everywhere. OniX is at the intersection of innovation, bringing universities, other not-for profit research organizations, the community and industry to work collaboratively to advance ideas to market. Universities are where innovation is happening around the globe, and where the big questions are being asked. The community has the on-ground knowledge of their challenges and needs to be addressed, and industry has the know-how of how to translate ideas to market.
​
Empowering the Research Community:
OniX serves as a dynamic hub, providing the research community with easy access to a comprehensive dataset. This user-friendly platform keeps researchers informed about the latest technological advancements, fostering an environment where knowledge flows seamlessly.
​
Transforming Drug Discovery:
Our mission is to revolutionize drug discovery by facilitating the identification of potential partners, drug targets, and applications for existing candidates. By bridging the gap between public and non-public data, OniX accelerates the transformation of research insights into effective medicines, ensuring that groundbreaking discoveries reach every patient in need.
Explore the power of OniX's AI-driven technologies — where innovation meets intelligence, and drug discovery is transformed for the betterment of global healthcare.
OniX aggregates the Research Ecosystem
All Ideas have an impact
OniX accepts ideas from a wide spectrum of research, including: Health Sciences, Biotechnology, Medical Devices, Agriculture, Energy, Space, Transportation, Climate Change, Food and Nutrition, Farming, Fisheries, Social Sciences, Public Health, Artificial Intelligence, Software/Hardware, and others.
Universities Research Enterprise
Knowledge and Innovation
OniX aggregates the entire research knowledge enterprise including (1) Funded Grant Applications, (2) Unfunded Grant Applications, (3) Startups and Incubators projects, (4) Intramural Funded Projects, (5) Technology Transfer Assets and (6) Others. These includes assets at the discovery, preclinical and clinical stage, and products in the market.
Industry
Bringing technologies to market
OniX works with industry to showcase their areas of interest, assets/products for partnering, and others. Industry assets include all stages from discovery to Phase IV.
Private Foundations & Charities
High-risk, High-reward
OniX partners with private foundations to include their funded and unfunded projects in the hub. Foundations assets are mainly at the the discovery, preclinical and some at the clinical stage.
Government
Advancing discovery and innovation
OniX includes funded grants and technology transfer assets from global research government funding agencies, i.e., US National Institutes of Health, the National Science Foundation, Canada Institutes of Health Research, EU Commission, UK Medical Research Council, Australia National Health and Medical Research Council, Japan Agency for Medical Research and Development and others. Government assets include from discovery to Phase 3.
Publications
Share the knowledge
OniX Includes publications from over 30 thousands journals
Patents
Innovation protected
OniX Includes patents from over 100 offices globally
Clinical Trials
Testing new treatments
OniX includes clinical trials from over 200 countries
Research News
News that matters
OniX proprietary algorithm scan the research news landscape daily and matches it to targets of interest
Our Technology
OniX employs a cutting-edge AI system that leverages machine learning, natural language processing, and cognitive reasoning technologies to empower the identification of novel partners, new drug targets, and potential applications for existing drug candidates. Our platform seamlessly integrates a distinctive collection of both public and non-public global data, creating an intuitive hub designed for the research community.
Key Technological Features:
-
Machine Learning: OniX utilizes advanced machine learning algorithms to sift through vast datasets, enabling the identification of promising partners and potential drug targets with enhanced accuracy.
-
Natural Language Processing (NLP): Our NLP capabilities enable the system to comprehend and process human language, facilitating a more intuitive and effective user experience.
-
Cognitive Reasoning: OniX incorporates cognitive reasoning technologies, allowing for intelligent decision-making and insights, thereby supporting researchers in making informed choices.​
The OniX Team
Founder/CEO
+25 years of experience in academia and private foundations including Columbia University College of Physicians & Surgeons, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, NYU School of Medicine, JDRF (previously Juvenile Diabetes Research Foundation), the Patient-Centered Outcomes Research Institute (PCORI) and Leidos.
-
OniX Empire Fund - Founder/CEO
-
The Lay Empowered - Founder
Previously:
-
OnPAR - Founder
-
Leidos Life Sciences - Director
-
Patient-Centered Outcomes Research Institute (PCORI) - Founder/Director
-
JDRF - COO of Research Department
-
New York University School of Medicine - Director
-
Hospital for Special Surgery - Associate Director
-
Memorial Sloan Kettering Cancer Center - Manager
-
Weil Cornell Medical College - Faculty
-
Columbia University Vagelos College of Physicians and Surgeons, Research Associate
Hadi Makki
Chief Technology Officer
Result-minded executive focused on increasing the value of the organization through rigorous strategic planning, business process engineering and effective cost management. Excels in fostering growth in business through meticulous profit & loss management, forming strategic alliances and tactical leadership. Exceptional communication and interpersonal skills, highly effective across all organizational levels.
Career Highlights
-
Transformed and set new standards for the use of Information Technology in the largest and most influential health department in the country (New York City)
-
Created and held key senior executive positions in both public and private sectors and drove business growth through strategic thinking, rigorous planning and execution, innovation and change